JOURNAL OF CARDIAC FAILURE《心力衰竭杂志》 （官网投稿）

万维提示：

1、投稿方式：在线投稿。

2、期刊网址：

https://www.journals.elsevier.com/journal-of-cardiac-failure

3、投稿网址：

https://www.editorialmanager.com/cardfail

4、官网邮箱：mhurt@hfsa.org（编辑部）

5、期刊刊期：月刊，一年出版12期。

2021年7月15日星期四

投稿须知【官网信息】

Guide for Authors

Introduction

The Journal of Cardiac Failure publishes peer-reviewed manuscripts of interest to clinicians, researchers and patients in the field of heart failure and related disciplines. These include:

original communications of scientific importance

review articles involving clinical research

health services and outcomes research

animal studies

design of ongoing clinical trials

editorial perspectives that comment on new developments pertinent to the field of heart failure or manuscripts published in other journals

bench research with potential clinical applications to clinical heart failure

Please review the NEW SUBMISSIONS (jump link) section of these instructions to review all Paper Categories.

We request that all manuscripts be submitted online at https://www.editorialmanager.com/cardfail

Double Blind Peer Reviews:

JCF utilizes Double Blind Peer Review, where the identities of both reviewers and authors are concealed from each other throughout the review. To facilitate this, authors must ensure that their manuscripts are prepared in such a way that they do not reveal their identities to reviewers, either directly or indirectly.

We ask authors to do their best to ensure that the following items are present in their submission and are provided as separate files:

1. Title page

The title page will remain separate from the manuscript throughout the peer review process and will not be sent to the reviewers. It should include:

The manuscript title

All authors' names and affiliations

A complete address for the corresponding author, including an e-mail address

Acknowledgements

Conflict of interest statement

2. Anonymised manuscript

Please remove any identifying information, such as authors' names or affiliations, from your manuscript before submission.

As well as removing names and affiliations under the title within the manuscript, other steps need to be taken to ensure the manuscript is correctly prepared for double-blind peer review. The key points to consider are:

Use the third person to refer to work the authors have previously published. For example, write "Black and Hart (2015) have demonstrated" rather than "we/the authors have previously demonstrated (Black and Hart, 2015)".

Make sure that figures and tables do not contain any reference to author affiliations Exclude acknowledgements and any references to funding sources. Use the title page, which is not sent to reviewers, to detail these and to declare any potential conflicts of interest to the editor.

Choose file names with care,and ensure that the file's "properties" are also anonymised. If using Microsoft Office 2007 or later, consider using the Document Inspector Tool prior to submission.

Take care to ensure that you do not inadvertently upload identifying information within any of the files that will be shared with reviewers. All file types except title page, cover letter and LaTeX source files are typically included in the version of your manuscript shared with reviewers.

Inclusive Language:

We request that manuscript submissions use sensitive and respectful language. Brief examples are listed below however authors should go to https://apastyle.apa.org/style-grammar-guidelines/bias-free-language for a full view of preferred language. In general, ask how someone prefers to be identified.

We also ask authors to consider that pre-specifying subgroup analyses of study endpoints are clear across diverse patients. While we recognize that not all submissions will have adequate means for these analyses, their inclusion supports progress on prioritizing diversity. We prioritize clinical research and patient perspective across the age spectrum from pediatric through geriatrics.

We emphasize the importance of incorporating the patient voice and perspective into manuscripts. We request that all Original Research and Review submissions include two "Visual Take-Home" graphics that summarize the research - one for the healthcare professional medical community and one for patients living with heart failure and their communities. We also require a brief lay summary so that the research results can be shared more broadly.

Please review the JCF Diversity Statement prior to submission.

Acceptance of Reviewer Comments from Other Journals - JCF "Court of Appeals"

Authors may submit previous peer review comments from other cardiology journals from which their manuscript has been rejected (as well as responses to these comments) in their initial submission as supplemental materials. These reviews will be considered by the editors in their initial review of the paper. Authors should indicate in their cover letter the inclusion of these reviews.

Figures in Color

Color figures are preferred.

All figures submitted in color will print in 4-color at no cost to the author.

Contact details

Authors may send queries concerning the submission process, manuscript status, or journal procedures to the Editorial Office, mhurt@hfsa.org.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

Ethics in publishing

Please see our information on Ethics in publishing.

Human and animal rights

Published research must be in compliance with human studies guidelines and animal welfare regulations. Authors should indicate in the manuscript that human subjects have given informed consent and that the institutional committee on human research has approved the study protocol. This consent statement should appear in the both the disclosure section as well as in the body of the manuscript. Similarly, they should indicate that studies involving experimental animals conform to institutional standards. In addition, authors should note in the body of the text a statement of adherence to guidelines for rigorous report of results, especially regarding methods. This should be in a separate section before References.

Conflict of interest

If a potential conflict exists, its nature should be stated for each author and the information should be outlined in the Disclosure section of the manuscript. When there is a stated potential conflict of interest and the editors consider that it may have relevance to the accompanying paper, a footnote will be added indicating the author(s)' equity interest in or other affiliation with the identified commercial firms.

All potential conflicts of interest must be identified within the text of the manuscript, under the conflicts with interest heading. This includes relationships with pharmaceutical and biomedical device companies or other corporations whose products or services are related to the subject matter of the article. Such relationships include, but are not limited to, employment by an industrial concern, equity or stock ownership by authors or family member, membership on a standing advisory council or committee, being on the board of directors or publicly associated with the company or its products. Other areas of real or perceived conflict of interest could include receipt of honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations. See also https://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at: https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing. If there are "none" this should be stated in the Disclosure section.

Submission form

Original works will be accepted with the understanding that they are contributed solely to the Journal of Cardiac Failure, are not under review by another publication, and have not previously been published except in abstract form. Accepted manuscripts become the sole property of the journal and may not be published elsewhere without the consent of the Journal of Cardiac Failure. A form stating that the authors transfer all copyright ownership to the journal will be sent from the publisher when the manuscript is accepted.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Preprints

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Contributors

Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure. Co-first authorship in cases wherein two authors have contributed equally is permitted.

Authorship

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. These are in consistent with ICMJE standards, which can be found at http://ww.icmje.org/icmje-recommendations.pdf.

Changes to authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.

Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

Copyright

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.

For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.

Author rights

As an author you (or your employer or institution) have certain rights to reuse your work. More information.

Elsevier supports responsible sharing

Find out how you can share your research published in Elsevier journals.

Role of funding sources

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to describe briefly the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Please see https://www.elsevier.com/funding.

Open access

Please visit our Open Access page for more information.

Elsevier Researcher Academy

Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.

Language (usage and editing services)

Manuscripts should be written in good English. Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop https://webshop.elsevier.com/language-editing-services/language-editing/ or visit our customer support site https://service.elsevier.com for more information.

Informed Consent and patient details

Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.

By submitting an article to the journal, all authors of the submission agree to receive emails from JCF regarding the manuscript, including editorial queries while the manuscript is under review and emails from the publisher should the paper be accepted for publication. The contact information provided by the corresponding author will be included in the galley proofs, the published PDF version of the manuscript, and the online version of the manuscript.

Submission

The Journal of Cardiac Failure uses an online, electronic submission system. By accessing the website https://www.editorialmanager.com/cardfail authors will be guided stepwise through the creation and uploading of the various files. When submitting a manuscript to Editorial Manager, authors need to provide an electronic version of their manuscript. For this purpose original source files, not PDF files, are preferred. The author should specify a category designation for the manuscript (original investigation, review article, brief communication, etc.) and choose a set of classifications from the prescribed list provided online. Once the submission files are uploaded, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the editor's decision and request for revisions, will be by e-mail.

Submit your article

Please submit your article via https://www.editorialmanager.com/cardfail.

……

更多详情：

https://www.elsevier.com/journals/journal-of-cardiac-failure/1071-9164/guide-for-authors